Insmed INC Form 4 insider transactions

Sara Bonstein, CFO of Insmed Inc., reports acquisition of restricted stock units and stock options, as well as the sale of common stock to cover tax obligations.

Roger Adsett, Chief Operating Officer of Insmed Inc., reports acquisition of restricted stock units and stock options, as well as the sale of common stock to cover tax obligations.

Director Melvin Sharoky reports acquisition of 13,162 Restricted Stock Units (RSUs) in Insmed Inc. on May 13, 2024.

Director Carol Schafer reports acquisition of 13,162 Restricted Stock Units (RSUs) in Insmed Inc. on May 13, 2024.

Director David W.J. McGirr acquired 13,162 shares of Insmed Inc. through Restricted Stock Units (RSUs) on May 13, 2024.

Director Leo Lee acquired 13,162 shares of Insmed Inc. common stock in the form of Restricted Stock Units (RSUs) on May 13, 2024.

Director Clarissa Desjardins reports acquisition of 13,162 Restricted Stock Units (RSUs) in Insmed Inc. on May 13, 2024.

Director David R. Brennan acquired 13,162 Restricted Stock Units (RSUs) of Insmed Inc. on May 13, 2024.

Director Elizabeth M. Anderson acquired 13,162 Restricted Stock Units (RSUs) of Insmed Inc. on May 13, 2024, increasing her total holdings to 68,671 shares.

Director Alfred Altomari acquired 13,162 Restricted Stock Units (RSUs) of Insmed Inc. on May 13, 2024.

William Lewis, Chair and CEO of Insmed Inc., exercised stock options and adjusted his reported beneficial ownership due to a clerical error.

Director Melvin Sharoky reports a gift of Insmed shares and updates to beneficial ownership, including holdings through family trusts and entities.